Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

EAPP, a novel E2F binding protein that modulates E2F-dependent transcription.

Novy M, Pohn R, Andorfer P, Novy-Weiland T, Galos B, Schwarzmayr L, Rotheneder H.

Mol Biol Cell. 2005 May;16(5):2181-90. Epub 2005 Feb 16.

2.

Upregulation of E2F transcription factors in chemically induced mouse skin tumors.

Balasubramanian S, Ahmad N, Mukhtar H.

Int J Oncol. 1999 Aug;15(2):387-90. Review.

PMID:
10402252
3.

Rb/E2F: a two-edged sword in the melanocytic system.

Halaban R.

Cancer Metastasis Rev. 2005 Jun;24(2):339-56. Review.

PMID:
15986142
4.

Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer.

Seville LL, Shah N, Westwell AD, Chan WC.

Curr Cancer Drug Targets. 2005 May;5(3):159-70. Review.

PMID:
15892617
5.

E2F1 pathways to apoptosis.

Ginsberg D.

FEBS Lett. 2002 Oct 2;529(1):122-5. Review.

6.

Life and death decisions by E2F-1.

Bell LA, Ryan KM.

Cell Death Differ. 2004 Feb;11(2):137-42. Review.

7.

Molecular mechanisms of E2F-dependent activation and pRB-mediated repression.

Frolov MV, Dyson NJ.

J Cell Sci. 2004 May 1;117(Pt 11):2173-81. Review.

8.

Emerging roles for E2F: beyond the G1/S transition and DNA replication.

Cam H, Dynlacht BD.

Cancer Cell. 2003 Apr;3(4):311-6. Review.

9.

Hitting their targets: an emerging picture of E2F and cell cycle control.

Blais A, Dynlacht BD.

Curr Opin Genet Dev. 2004 Oct;14(5):527-32. Review.

PMID:
15380244
10.

Cell cycle molecules and vertebrate neuron death: E2F at the hub.

Greene LA, Biswas SC, Liu DX.

Cell Death Differ. 2004 Jan;11(1):49-60. Review.

11.

Role of E2F1 in apoptosis: a case study in feedback loops.

Knezevic D, Brash DE.

Cell Cycle. 2004 Jun;3(6):729-32. Epub 2004 Jun 6. Review.

PMID:
15107604
12.

Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation.

Senger DR, Perruzzi CA, Papadopoulos A.

Anticancer Res. 1989 Sep-Oct;9(5):1291-9. Review.

PMID:
2686530
13.

Turning cell cycle controller genes into cancer drugs. A role for an antiproliferative cytokine (betaGBP).

Mallucci L, Wells V, Danikas A, Davies D.

Biochem Pharmacol. 2003 Oct 15;66(8):1563-9. Review.

PMID:
14555235
14.

Regulation in S phase by E2F.

Pardee AB, Li CJ, Reddy GP.

Cell Cycle. 2004 Sep;3(9):1091-4. Epub 2004 Sep 4. Review.

PMID:
15467444
15.

Phylogenetics and functions of the double-stranded RNA-binding motif: a genomic survey.

Tian B, Mathews MB.

Prog Nucleic Acid Res Mol Biol. 2003;74:123-58. Review. No abstract available.

PMID:
14510075
16.

Molecular therapy via transcriptional regulation with double-stranded oligodeoxynucleotides as decoys.

Nakamura H, Morishita R, Kaneda Y.

In Vivo. 2002 Jan-Feb;16(1):45-8. Review.

PMID:
11980360
17.

The genetics of the E2F family of transcription factors: shared functions and unique roles.

DeGregori J.

Biochim Biophys Acta. 2002 Jun 21;1602(2):131-50. Review. No abstract available.

PMID:
12020800
18.

Analysis of transcription factor remodeling in phase II gene expression with curcumin.

Dickinson DA, Iles KE, Wigley AF, Forman HJ.

Methods Enzymol. 2004;378:302-18. Review. No abstract available.

PMID:
15038977
19.

Transcriptional tools for aging research.

Case CC.

Mech Ageing Dev. 2003 Jan;124(1):103-8. Review.

PMID:
12618012
20.

Transient transfection of Schneider cells in the study of transcription factors.

Suske G.

Methods Mol Biol. 2000;130:175-87. Review. No abstract available.

PMID:
10589431

Supplemental Content

Support Center